Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/29/2026

1. WDAY
2. ESTC
3. MRVL
4. AFRM
5. RBRK
6. S
7. GAP
8. DG
9. ULTA
10. NVDA

Go back to Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program
(NASDAQ: ZNTL) Delayed: 3.80 -0.08 (2.06%)
Previous Close $3.88    52 Week High $ 
Open $3.88    52 Week Low $ 
Day High $3.89    P/E N/A 
Day Low $3.72    EPS $ 
Volume 695,396